MissionIR's  Instablog

A recent article in Seeking Alpha by Greg Miller (http://dtg.fm/Ae6X) explores the most recent investment activities of one of America's most accomplished investors, a medical doctor and entrepreneur with a remarkably accurate eye for potentials in the pharmaceutical industry, though now branching into other industries as well.

By training, Dr. Phillip Allen Gamma Frost was a medical doctor, a graduate of the Albert Einstein College of Medicine in New York. After working with the U.S. Public Health Service and as a Professor of Dermatology at the University of Miami, he became Chairman of the Dermatology Department at Mt. Sinai Medical Center of Greater Miami in 1972. It was at the same time that Frost, together with partner Michael Jaharis, were able to purchase Key Pharmaceuticals. The company produced generic pharmaceuticals, and Frost's development of new delivery systems helped grow the company to a successful sale to Schering-Plough 14 years later. Taking the money made from the sale, Frost founded drug producer Ivax Corporation, which went on to be sold in 2006 to Israeli-based international pharmaceutical company Teva Pharmaceuticals (TEVA), the world's largest producer of generic drugs, for $7.6 billion. Dr. Frost now sits as Chairman of the Board of Teva.

But the article points to Dr. Frost's other investment successes, his achievements in small cap companies, most but not all related to medical/pharma. Most noteworthy were his investments in Whitman Education, where a $6 million investment became $175 million, a 2800% gain; North American Vaccine, where a $10 million investment became $140 million, a 1300% gain; Continuecare, where a $16.8 million investment became $170 million, a 900% gain; and several others.

Of more recent interest are his major holdings in Opko Health (OPK), which has nearly doubled in price over the past two months. Today Dr. Frost's investment insights are themselves becoming a factor, with his recent investment in MusclePharm (MSLP) helping drive a sharp spike in share price. Dr. Frost's latest 13G filings are for Continental Resources Group (CRGC.OB), which is in the process of completing a share exchange with Frost favorite Pershing Gold (PGLC), and IZEA Inc. (IZEA.PK), a social media company.

Sign up for "The Mission Report" at www.MissionIR.com